Evidence map›Paper›PMID 41173316›Full record

ArticleFree radical biology & medicine2026

A paradigm-expanding role for albumin: Metal-free, protein-mediated nitrite bioactivation.

Hannah J Naldrett, Partha S Sheet, Steven P Schwendeman, Gergely Lautner

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hannah J NaldrettDepartment of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109, USA.
Partha S SheetDepartment of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109, USA.
Steven P SchwendemanDepartment of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109, USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: schwende@umich.edu.
Gergely LautnerDepartment of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: glautner@umich.edu.

Funding

Research Supplement to Promote Diversity Supplement for the ECMO without AnticoagulationR01HL155100 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROJAS-PENA, ALVARO · 2021 to 2024
$3.2M
Electrochemically Generated Inhaled Nitric Oxide (iNO) delivery via High Flow Nasal Cannula (HFNC)R01HL168099 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Gergely Lautner · 2023 to 2026
$2.2M
Controlled Photochemical Release of Nitric Oxide for Biomedical ApplicationsR01EB028775 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHWENDEMAN, STEVEN P. · 2020 to 2023
$1.8M
NHLBI NIH HHS R01 HL155100NHLBI NIH HHS R01 HL168099NIBIB NIH HHS R01 EB028775
6 · The paper itself

Abstract

Nitric oxide (NO) radical has remarkable importance due to its involvement in virtually all physiological and pathophysiological processes. It is a critical regulatory mediator and effector molecule of the cardiovascular-, nervous- and immune systems. Nitrite is recognized as a biologic reservoir of NO bioactivity. The nitrite-to-NO conversion that enables the release and signaling competence of NO is traditionally attributed to heme-containing proteins. Here, we demonstrate that human serum albumin, the most abundant plasma protein, can also mediate the conversion of nitrite to NO via its conserved cysteine-34 residue. We propose that upon oxidation to sulfenic acid, Cys-34 reacts with nitrite to form a sulfenyl nitrite intermediate, which decomposes to liberate bioactive NO. This unveils a previously unrecognized, non-heme, protein-based route for nitrite bioactivation and expands our understanding of NO homeostasis. These findings introduce new perspectives for therapeutic modulation of redox signaling pathways and reshapes the understanding of NO generation in biological systems.

Indexed as

Nitric OxideNitritesSerum Albumin, HumanCysteineHumansOxidation-ReductionSignal TransductionCysteineNitric OxideNitritesSerum Albumin, HumanAlbuminNitric oxideNitriteSulfenic acid

Identifiers

PMID41173316
PMCPMC12811008

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.